EVALUATION OF NEUROLOGIC EFFECTS OF SOME NEW IBUPROFEN THIAZOLIDIN-4-ONE DERIVATIVES
DOI:
https://doi.org/10.22551/2y5ek210Abstract
Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, are widely used to treat pain and inflammation associated with various conditions, including neurodegenerative diseases. The aim of this study was to evaluate the neurological effects of several new ibuprofen derivatives containing a thiazolidin-4-one moiety. Materials and methods. The effects of ibuprofen-thiazolidine-4-one derivatives (4a-n) on neuromotor function and locomotor activity in mice were assessed using the Rota-rod and locomotor activity tests. The compounds were administered orally by gavage, as a suspension in tween 80, at a single daily dose equivalent to 1/20 of the LD50. A reference group, which received ibuprofen, and a control group, which received tween 80, were also used. Results: The ibuprofen-thiazolidine-4-one derivatives (4a-n) did not produce statistically significant changes in neuromotor performance, at any of the three time points assessed (1 hour, 2 hours, 6 hours post-administration). However, a significant decrease in total locomotor activity-both horizontal and vertical movements—was observed with compound 4b. Notably, several derivatives also led to a marked reduction in vertical movements. Conclusions: The observed decrease in vertical movements for some ibuprofen thiazolidine-4-one derivatives may indicate a potential anxiolytic effect, though this hypothesis requires validation through further studies.
References
1. Vasincu IM, Apotrosoaei M, Constantin S, et al. New ibuprofen derivatives with thiazolidine-4-one scaffold with improved pharmaco-toxicological profile. BMC Pharmacol Toxicol 2021; 22(1):10.
2. Tsoupras A, Gkika DA, Siadimas I, Christodoulopoulos I, Efthymiopoulos P, Kyzas GZ. The Multi-faceted Effects of Non-Steroidal and Non-Opioid Anti-Inflammatory and Analgesic Drugs on Platelets: Current Knowledge, Limitations, and Future Perspectives. Pharmaceuticals 2024; 17(5): 627.
3. Vasincu I, Apotrosoaei M, Panzariu AT, Buron F, Routier S, Profire L. Synthesis and Biological Evaluation of New 1,3-Thiazolidine-4-one Derivatives of 2-(4-Isobutylphenyl)propionic Acid. Mole-cules 2014; 19(9): 15005-15025.
4. Alvez FL, Bona NP, Pedra NS, et al. Effect of Thiazolidin-4-one Against Lipopoly-saccharide-Induced Oxidative Damage, and Alterations in Adenine Nucleotide Hydrolysis and Acetylcholinesterase Activity in Cultured Astrocytes. Cell Mol Neurobiol 2023; 43(1): 283-297.
5. De Souza AA, Goularte KCM, Piccoli RC, et al. 3-(3-(diethylamino) propyl)-2-(4-(methylthio) phe-nyl)thiazolidin-4-one Attenuates Scopolamine-induced Cognitive Impairment in Rats: Insights Into Neuroprotective Effects. Mol Neurobiol 2025 / doi: 10.1007/s12035-025-04887-5.
6. Dos Santos A, Teixeira FC, Da Silva DS, et al. Thiazolidin-4-one prevents against memory deficits, increase in phosphorylated tau protein, oxidative damage and cholinergic dysfunction in Alzheimer disease model: Comparison with donepezil drug. Brain Res Bull 2023; 193: 1-10.
7. Apotrosoaei M, Vasincu IM, Constantin SM, et al. The effects of new 1,3-thiazolidine-4-ones with pyrrazolone scafold on motor function in mice. Farmacia 2019; 67(2): 305-310.
8. Vieira CP, Lelis CA, Ochioni AC, Rosário DKA, Rosario ILS, Vieira IRS, et al. Estimating the ther-apeutic potential of NSAIDs and linoleic acid-isomers supplementation against neuroinflammation. Biomed Pharmacother 2024; 177: 116884.
9. Montaser AB, Kuiri J, Natunen T, et al. Enhanced drug delivery by a prodrug approach effectively relieves neuroinflammation in mice. Life Sci 2022; 310: 121088.
10. Mottaghi S, Kohl S, Biemann D, et al. Bilateral Intracranial Beta Activity During Forced and Sponta-neous Movements in a 6-OHDA Hemi-PD Rat Model. Front Neurosci 2021; 15: 700672.
11. Vuckovic S, Prostran M, Ivanovic M, et al. Pharmacological Evaluation of 3-Carbomethoxy Fentanyl in Mice. Pharmaceuticals 2011; 4(2): 233-243.
12. De Souza ÉT, Pereira De Lira D, Cavalcanti De Queiroz A, et al. The Antinociceptive and Anti-Inflammatory Activities of Caulerpin, a Bisindole Alkaloid Isolated from Seaweeds of the Genus Caulerpa. Marine Drugs 2009; 7(4): 689-704.
13. Stroobants S, Gantois I, Pooters T, D’Hooge R. Increased gait variability in mice with small cerebellar cortex lesions and normal rotarod performance. Behav Brain Res 2013; 241: 32-37.
14. Singh A, Tripathi P, Prakash O, Singh MP. Ibuprofen abates cypermethrin-induced expression of pro-inflammatory mediators and mitogen-activated protein kinases and averts the nigrostriatal dopaminergic neurodegeneration. Mol Neurobiol 2016; 53(10): 6849-6458.
15. Lynch JJ, Castagné V, Moser PC, Mittelstadt SW. Comparison of methods for the assessment of locomotor activity in rodent safety pharmacology studies. J Pharmacol Toxicol Methods 2011; 64(1): 74-80.
16. Lee B, Sur B, Yeom M, Shim I, Lee H, Hahm DH. Effects of systemic administration of ibuprofen on stress response in a rat model of post-traumatic stress disorder. Korean J Physiol Pharmacol 2016; 20(4): 357.
Additional Files
Published
Issue
Section
License
Copyright (c) 2025 The Medical-Surgical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
COPYRIGHT
Once an article is accepted for publication, MSJ requests a transfer of copyrights for published articles.
COPYRIGHT TRANSFER FORM FOR
REVISTA MEDICO-CHIRURGICALĂ A SOCIETĂȚII DE MEDICI ȘI NATURALIȘTI DIN IAȘI /
THE MEDICAL-SURGICAL JOURNAL OF THE SOCIETY OF PHYSICIANS AND NATURALISTS FROM IASI
We, the undersigned authors of the manuscript entitled
_____________________________________________________________________________________
_____________________________________________________________________________________
warrant that this manuscript, which is submitted for publication in the REVISTA MEDICO-CHIRURGICALĂ, has not been published and it is not under consideration for publication in another journal.
- we give the consent for publication in the REVISTA MEDICO-CHIRURGICALĂ, in printed and electronic format and we transfer unconditioned and complete the copyright of this manuscript to the REVISTA MEDICO-CHIRURGICALĂ, in the event of its acceptance.
- the manuscript does not break the intellectual property rights of any other person.
- we have read the submitted version of the manuscript and we are fully responsible for the content.
Names and signatures of authors / copyright owners (the following sequence is the authorship of the article):
- ______________________________/_________________________
- ______________________________/_________________________
- ______________________________/_________________________
N.B. All the authors must sign this form
